亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

医学 耐受性 免疫原性 不利影响 接种疫苗 病毒学 内科学 免疫学 抗体 安慰剂 随机对照试验 血清转化 重组DNA
作者
Fengcai Zhu,Yuhua Li,Xuhua Guan,Lihua Hou,Wenjuan Wang,Jingxin Li,Shipo Wu,Busen Wang,Xiaolong Yang,Lei Wang,Siyue Jia,Hu-Dachuan Jiang,Ling Wang,Tao Jiang,Yi Hu,Jin-Bo Gou,Shabei Xu,Hong Shang,Xuewen Wang,Wei Wang,Wei Chen
出处
期刊:The Lancet [Elsevier BV]
卷期号:395 (10240): 1845-1854 被引量:956
标识
DOI:10.1016/s0140-6736(20)31208-3
摘要

A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the spike glycoprotein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain.We did a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of an Ad5 vectored COVID-19 vaccine in Wuhan, China. Healthy adults aged between 18 and 60 years were sequentially enrolled and allocated to one of three dose groups (5 × 1010, 1 × 1011, and 1·5 × 1011 viral particles) to receive an intramuscular injection of vaccine. The primary outcome was adverse events in the 7 days post-vaccination. Safety was assessed over 28 days post-vaccination. Specific antibodies were measured with ELISA, and the neutralising antibody responses induced by vaccination were detected with SARS-CoV-2 virus neutralisation and pseudovirus neutralisation tests. T-cell responses were assessed by enzyme-linked immunospot and flow-cytometry assays. This study is registered with ClinicalTrials.gov, NCT04313127.Between March 16 and March 27, 2020, we screened 195 individuals for eligibility. Of them, 108 participants (51% male, 49% female; mean age 36·3 years) were recruited and received the low dose (n=36), middle dose (n=36), or high dose (n=36) of the vaccine. All enrolled participants were included in the analysis. At least one adverse reaction within the first 7 days after the vaccination was reported in 30 (83%) participants in the low dose group, 30 (83%) participants in the middle dose group, and 27 (75%) participants in the high dose group. The most common injection site adverse reaction was pain, which was reported in 58 (54%) vaccine recipients, and the most commonly reported systematic adverse reactions were fever (50 [46%]), fatigue (47 [44%]), headache (42 [39%]), and muscle pain (18 [17%]. Most adverse reactions that were reported in all dose groups were mild or moderate in severity. No serious adverse event was noted within 28 days post-vaccination. ELISA antibodies and neutralising antibodies increased significantly at day 14, and peaked 28 days post-vaccination. Specific T-cell response peaked at day 14 post-vaccination.The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post-vaccination. Humoral responses against SARS-CoV-2 peaked at day 28 post-vaccination in healthy adults, and rapid specific T-cell responses were noted from day 14 post-vaccination. Our findings suggest that the Ad5 vectored COVID-19 vaccine warrants further investigation.National Key R&D Program of China, National Science and Technology Major Project, and CanSino Biologics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不秃燃的小老弟完成签到 ,获得积分10
39秒前
59秒前
Owen应助科研通管家采纳,获得10
1分钟前
年年有余完成签到,获得积分10
1分钟前
胖小羊完成签到 ,获得积分10
2分钟前
3分钟前
领导范儿应助科研通管家采纳,获得10
3分钟前
3分钟前
juan完成签到 ,获得积分10
4分钟前
学术小垃圾完成签到,获得积分10
4分钟前
叁月二完成签到 ,获得积分10
4分钟前
4分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
大模型应助科研通管家采纳,获得10
5分钟前
xingsixs完成签到 ,获得积分10
5分钟前
AprilLeung完成签到 ,获得积分10
6分钟前
7分钟前
深情安青应助科研通管家采纳,获得10
7分钟前
迷茫的一代完成签到,获得积分10
8分钟前
魔笛的云宝完成签到 ,获得积分10
8分钟前
www完成签到,获得积分10
8分钟前
8分钟前
NexusExplorer应助科研通管家采纳,获得10
9分钟前
Akitten发布了新的文献求助10
9分钟前
啥时候吃火锅完成签到 ,获得积分0
10分钟前
上官若男应助科研通管家采纳,获得30
11分钟前
斯文败类应助科研通管家采纳,获得10
11分钟前
李爱国应助科研通管家采纳,获得10
11分钟前
科研通AI2S应助科研通管家采纳,获得10
11分钟前
赘婿应助科研通管家采纳,获得10
11分钟前
田様应助精明晓刚采纳,获得10
11分钟前
11分钟前
精明晓刚发布了新的文献求助10
11分钟前
科研通AI2S应助科研通管家采纳,获得10
13分钟前
coolplex完成签到 ,获得积分10
13分钟前
wwe完成签到,获得积分10
13分钟前
貔貅完成签到 ,获得积分10
14分钟前
yindi1991完成签到 ,获得积分10
16分钟前
hgl完成签到,获得积分10
16分钟前
17分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990423
求助须知:如何正确求助?哪些是违规求助? 3532158
关于积分的说明 11256513
捐赠科研通 3271046
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234